Pfizer Q3 preview: Analysts look to obesity pipeline amid diverging growth expectations
at seekingalpha.com (Mon, 2-Nov 10:54 AM)
Pfizer (PFE) Reports Q3 Earnings Tomorrow — Here’s Why Wall Street Remains Split
at www.tipranks.com (Mon, 2-Nov 7:02 AM)
Options Volatility and Implied Earnings Moves This Week, November 02 – November 06, 2026
at www.tipranks.com (Mon, 2-Nov 7:00 AM)
The Week That Was, The Week Ahead: Macro and Markets, November 1
at www.tipranks.com (Sun, 1-Nov 4:50 AM)
Earnings Scoreboard: 83% of reporting firms beat EPS estimates, 79% post Y/Y earnings growth
at seekingalpha.com (Sat, 31-Oct 11:45 AM)
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth
at seekingalpha.com (Sat, 31-Oct 10:40 AM)
Options Expect a Bigger Pfizer Move Than It Usually Makes After Earnings
Market Chameleon (Fri, 30-Oct 12:04 PM)
Catalyst watch: Election drama, jobs report, Apple and McDonald's in the earnings confessional
at seekingalpha.com (Fri, 30-Oct 3:00 PM)
Pfizer Targets Severe Asthma With Tilrekimig: What Investors Should Watch
at www.tipranks.com (Fri, 30-Oct 12:31 PM)
Pfizer Adds New Alzheimer’s Candidate to Early-Stage Pipeline With PF-08161842 Trial
at www.tipranks.com (Fri, 30-Oct 12:30 PM)
Pfizer’s Lorlatinib Gains Real World Momentum in China Lung Cancer Study
at www.tipranks.com (Fri, 30-Oct 12:30 PM)
Pfizer Targets PIK3CA-Mutated Cancers With New Phase 1 Study: What Investors Should Watch
at www.tipranks.com (Wed, 28-Oct 12:32 PM)
